HRSA/MCHB Newborn Screening Systematic Evidence Review IDIQ and Task Order 1

The Health Resources and Services Administration, Maternal and Child Health Bureau (HRSA/MCHB) is releasing this full and open competitive solicitation to establish a Multiple-Award pool of approximately three (3) to five (5) Indefinite-Delivery, Indefinite-Quantity (IDIQ) contracts. The primary objective is to secure highly specialized scientific methodologies, systematic clinical evidence reviews, and core programmatic support for the Newborn Screening Recommended Uniform Screening Panel (RUSP). The master IDIQ ordering period is five (5) years (a 12-month Base Period plus four sequential 12-month Option Periods) with an aggregate collective ceiling value of $15,111,361.00. 2. Acquisition…